2016
DOI: 10.3892/ijo.2016.3442
|View full text |Cite
|
Sign up to set email alerts
|

Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways

Abstract: Abstract. Currently, acquired resistance to cisplatin (DDP) is a substantial obstacle to reducing the morbidity and mortality due to ovarian malignant tumors. Nevertheless, cisplatin plays a vital role in killing the tumor cells while it may also be a 'primer' involved in chemotherapy resistance. We found that the cisplatin-induced chemokine (C-C motif) ligand 5 (CCL5) secretion derived from cancer-associated fibroblasts (CAFs) promoted ovarian cancer cell resistance to cisplatin. Via a cytokine chip assay, we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
65
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 75 publications
(66 citation statements)
references
References 43 publications
1
65
0
Order By: Relevance
“…For example, ADAM17-induced chemoresistance drug resistance in hepatocellular carcinoma cells [19]and RLIP76-induced drug resistance in pancreatic cancer cells [20]were regulated by PI3K/AKT pathway. Numerous studies have confirmed that PI3K/AKT can confer resistance to DDP-based treatment in cervical cancer[21, 22], lung cancer[22], and ovarian cancer[23]. In our study, four genes involved in this pathway, including NFKB1 , PPP2R5B , PPP2R2B , and CCNE2 , were significantly deregulated in the cisplatin-resistant cell line.…”
Section: Discussionsupporting
confidence: 74%
“…For example, ADAM17-induced chemoresistance drug resistance in hepatocellular carcinoma cells [19]and RLIP76-induced drug resistance in pancreatic cancer cells [20]were regulated by PI3K/AKT pathway. Numerous studies have confirmed that PI3K/AKT can confer resistance to DDP-based treatment in cervical cancer[21, 22], lung cancer[22], and ovarian cancer[23]. In our study, four genes involved in this pathway, including NFKB1 , PPP2R5B , PPP2R2B , and CCNE2 , were significantly deregulated in the cisplatin-resistant cell line.…”
Section: Discussionsupporting
confidence: 74%
“…Meanwhile, a recent study has illustrated that CAF-derived chemokine, namely CCL5, promotes cisplatin resistance by the regulation of PI3K/Akt signalling pathway in ovarian cancer cells [25]. Furthermore, up-regulation of GRP78 is also associated with inhibition of cell apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…PI3K/Akt signaling pathway plays an important role in tumorigenesis and regulates critical cellular functions including survival, proliferation, and metabolism . Cisplatin‐induced CCL5 secretion derived from the CAFs may promote cisplatin resistance, which was mediated by regulation of the Stat3 and PI3K/Akt signal pathways . Moreover, endogenous Stat3 is acetylated at Lys‐685 by leukemia inhibitory factor or interleukin 6 through PI3K/Akt activation .…”
Section: Discussionmentioning
confidence: 99%